Abstract:HomeCirculationVol. 136, No. 22Letter by Jin-shan and Xue-bin Regarding Article, "Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)" Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBLetter by Jin-shan and Xue-bin Regarding Article, "Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)" He Jin-shan, MD and Li Xue-bin, MD He Jin-shanHe Jin-shan Department of Cardiology, Beijing Key Laboratory of Early Prediction and Intervention of Acute Myocardial Infarction, Peking University People's Hospital, Beijing, China. and Li Xue-binLi Xue-bin Department of Cardiology, Beijing Key Laboratory of Early Prediction and Intervention of Acute Myocardial Infarction, Peking University People's Hospital, Beijing, China. Originally published28 Nov 2017https://doi.org/10.1161/CIRCULATIONAHA.117.030674Circulation. 2017;136:2202–2203To the Editor:We read with great interest the article by Hoffmann and colleagues1 about the prognostic value of noninvasive cardiovascular testing in patients with stable chest pain. The article indicates that coronary computed tomography angiography (CTA) provides better prognostic information than functional testing in contemporary patients who have stable chest pain with a low burden of obstructive coronary artery disease, myocardial ischemia, and events. CTA operates by identifying patients at risk for nonobstructive coronary artery disease. This article is a randomized comparison of the ability of anatomic and functional testing to correctly classify risk in symptomatic patients and will have a large influence on the management of patients with stable chest pain.We have 3 suggestions. First, coronary atherosclerosis causing between 1% and 69% luminal narrowing has emerged as a significant and frequent finding that, although often not associated with myocardial ischemia, carries a substantial risk for major adverse cardiovascular events in comparison with patients without any coronary artery disease.2 CTA can visualize minimal nonobstructive coronary artery disease, even the plaques, and it can tell which kind of plaque is a high risk for causing clinical events. The coronary artery system has great compensation ability, and the functional test will be abnormal when the stenosis is severe and normal if not. CTA identifies additional at-risk patients and imparts better prognostic and discriminatory information than functional testing. Second, because CTA is preferable to functional testing in patients with stable chest pain, it should be used widely in clinical practice. Two areas of concern include allergy to the contrast agent and the x-ray dose. We need to improve the techniques to lower the x-ray dose and rate of allergy to the contrast agent. Third, functional testing provides better prognostic information in high-risk patients with severe stenosis, but during the testing, myocardial ischemia may be induced and leads to myocardial infarction for these patients. Considering both efficacy and safety, CTA is more suitable when managing patients with stable chest pain.He Jin-shan, MDLi Xue-bin, MDDisclosuresNone.FootnotesCirculation is available at http://circ.ahajournals.org.References1. Hoffmann U, Ferencik M, Udelson JE, Picard MH, Truong QA, Patel MR, Huang M, Pencina M, Mark DB, Heitner JF, Fordyce CB, Pellikka PA, Tardif JC, Budoff M, Nahhas G, Chow B, Kosinski AS, Lee KL, Douglas PS; PROMISE Investigators. Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain).Circulation. 2017; 135:2320–2332. doi: 10.1161/CIRCULATIONAHA.116.024360.LinkGoogle Scholar2. Hadamitzky M, Täubert S, Deseive S, Byrne RA, Martinoff S, Schömig A, Hausleiter J. Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease.Eur Heart J. 2013; 34:3277–3285. doi: 10.1093/eurheartj/eht293.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetails November 28, 2017Vol 136, Issue 22 Advertisement Article InformationMetrics © 2017 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.117.030674PMID: 29180500 Originally publishedNovember 28, 2017 PDF download Advertisement SubjectsDiagnostic TestingImaging

Letter by Jin-shan and Xue-bin Regarding Article, “prospective Study of Adenosine on Atrioventricular Nodal Conduction in Pediatric and Young Adult Patients after Heart Transplantation”

A Comparison Study on the Responses of Umbilical Arteries and Thoracic Aorts to the Adrenergic Receptor Agonists

Amino Acid Transport in Mammalian Oocytes

Effect of Adenosine on Electrophysiological Changes of Ventricular Myocardium in Rats with Experimental Diabetes

Value of the Adenosine Test for Diagnosis of Dual AV Nodal Physiology in Patients with AV Nodal Reentrant Tachycardia

Base compositional bias in trans-spliced sequences of unknown function in Leishmania major.

Three Hours Continuous Injection of Adenosine Improved Left Ventricular Function and Infarct Size in Patients with ST-segment Elevation Myocardial Infarction.

Letter by Jin-shan and Xue-bin Regarding Article, “idiopathic Ventricular Fibrillation in a 29-Year-old Man”

Management of Arrhythmias After Heart Transplant: Current State and Considerations for Future Research

First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial

Effect of Postablation Monitoring Strategy on Long-Term Outcome for Catheter Ablation of Persistent Atrial Fibrillation

Letter by Jin-shan and Xue-bin Regarding Article, "Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands with Brugada Syndrome: A Japanese Multicenter Registry".

Pathologic observations on congenital heart disease before and after surgery.

Initial experience with ablation of the innervation surrounding sinus and atrioventricular nodes to treat paroxysmal bradyarrhythmia

Letter to the Editor Regarding Article, “alternating Bundle-Branch Block: What is the Mechanism?”

Cardioneuroablation for successful treatment of symptomatic bradycardia in a 12-year-old child after a 6-month follow-up

High dose escalation of intracoronary adenosine in the assessment of fractional flow reserve: A retrospective cohort study

Management of Atrial Arrhythmias After Lung Transplant

Protective effect of adenosine A2A receptor activation in small-for-size liver transplantation.

Letter by Jin-shan and Xue-bin Regarding Article, “prognostic Value of Noninvasive Cardiovascular Testing in Patients with Stable Chest Pain: Insights from the PROMISE Trial (prospective Multicenter Imaging Study for Evaluation of Chest Pain)”

Therapeutic effect of radiofrequency ablation on children with supraventricular tachycardia and the risk factors for postoperative recurrence